drugset / Trial / NCT00073320

Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia

NCT00073320

RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to compare the pharmacokinetic parameters (blood concentrations) of i.m. paliperidone palmitate after administration in 2 different injection sites (deltoid or gluteal).

Timeline

Start
2003-08
Primary completion
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject paliperidone palmitate Unknown 25 mg Intramuscular
Subject paliperidone palmitate Unknown 150 mg Intramuscular

Indications